1. Home
  2. ULH vs LCTX Comparison

ULH vs LCTX Comparison

Compare ULH & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Logistics Holdings Inc.

ULH

Universal Logistics Holdings Inc.

HOLD

Current Price

$24.20

Market Cap

462.1M

Sector

Industrials

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.50

Market Cap

388.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULH
LCTX
Founded
1932
1990
Country
United States
United States
Employees
N/A
77
Industry
Trucking Freight/Courier Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.1M
388.6M
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
ULH
LCTX
Price
$24.20
$1.50
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$20.00
$6.25
AVG Volume (30 Days)
44.4K
1.0M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
1.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,461,708,000.00
$14,556,000.00
Revenue This Year
$2.73
$109.40
Revenue Next Year
$5.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$12.78
$0.43
52 Week High
$30.76
$2.09

Technical Indicators

Market Signals
Indicator
ULH
LCTX
Relative Strength Index (RSI) 63.68 43.20
Support Level $23.19 $1.44
Resistance Level $25.85 $1.80
Average True Range (ATR) 1.48 0.08
MACD -0.04 -0.01
Stochastic Oscillator 71.68 18.33

Price Performance

Historical Comparison
ULH
LCTX

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: